Furthermore, we found in the regression analyses that sCD163 levels were positively associated with the improvement of neurological functions but negatively associated with the risk of poor clinical outcomes, further supporting the hypothesis that monocyte activation may serve as a protective mechanism of neuronal injury repairment post-AIS. The gene discussed is CD163; the disease is androgen insensitivity syndrome.